Jazz Pharmaceuticals JAZZ Federal
Federal at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CurrentFederalTaxExpenseBenefit.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's federal.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's federal?
- Jazz Pharmaceuticals (JAZZ) reported federal of $17.91M in Q4 2025.
- How has Jazz Pharmaceuticals's federal changed year-over-year?
- Jazz Pharmaceuticals's federal decreased by 26.7% year-over-year, from $24.42M to $17.91M.
- What is the long-term trend for Jazz Pharmaceuticals's federal?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's federal has grown at a 29.1% compound annual growth rate (CAGR), from $25.77M to $71.63M.
- What does federal mean?
- The federal income tax currently owed or due back to the company.
- How do you interpret federal?
- Changes reflect fluctuations in taxable income and the impact of federal tax credits or legislative changes.
- How does federal compare across companies?
- Standard tax disclosure; compared against statutory rates to evaluate tax efficiency.